Covington Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $12.3M | Buy |
54,600
+232
| +0.4% | +$56.2K | 0.53% | 56 |
|
|
2022
Q2 | $13.2M | Sell |
54,368
-490
| -0.9% | -$120K | 0.54% | 53 |
|
|
2022
Q1 | $13.3M | Buy |
54,858
+7,234
| +15% | +$1.66M | 0.48% | 63 |
|
|
2021
Q4 | $10.7M | Buy |
47,624
+204
| +0.4% | +$43.1K | 0.37% | 77 |
|
|
2021
Q3 | $10.1M | Sell |
47,420
-518
| -1% | -$119K | 0.38% | 74 |
|
|
2021
Q2 | $11.7M | Buy |
47,938
+297
| +0.6% | +$73.1K | 0.46% | 65 |
|
|
2021
Q1 | $11.9M | Sell |
47,641
-180
| -0.4% | -$43K | 0.51% | 57 |
|
|
2020
Q4 | $11M | Buy |
47,821
+950
| +2% | +$219K | 0.5% | 61 |
|
|
2020
Q3 | $11.9M | Buy |
46,871
+1,005
| +2% | +$249K | 0.59% | 48 |
|
|
2020
Q2 | $10.8M | Sell |
45,866
-1,553
| -3% | -$354K | 0.6% | 46 |
|
|
2020
Q1 | $9.61M | Sell |
47,419
-2
| -0% | -$437 | 0.63% | 48 |
|
|
2019
Q4 | $11.4M | Sell |
47,421
-299
| -0.6% | -$65.9K | 0.6% | 48 |
|
|
2019
Q3 | $9.23M | Sell |
47,720
-826
| -2% | -$159K | 0.53% | 55 |
|
|
2019
Q2 | $8.95M | Buy |
48,546
+86
| +0.2% | +$15.4K | 0.53% | 53 |
|
|
2019
Q1 | $9.21M | Buy |
48,460
+550
| +1% | +$105K | 0.57% | 51 |
|
|
2018
Q4 | $9.33M | Buy |
47,910
+2,544
| +6% | +$496K | 0.65% | 46 |
|
|
2018
Q3 | $9.4M | Sell |
45,366
-288
| -0.6% | -$56.8K | 0.58% | 54 |
|
|
2018
Q2 | $8.43M | Buy |
45,654
+197
| +0.4% | +$34.8K | 0.54% | 54 |
|
|
2018
Q1 | $7.75M | Buy |
45,457
+2,561
| +6% | +$470K | 0.51% | 60 |
|
|
2017
Q4 | $7.46M | Buy |
42,896
+240
| +0.6% | +$42.5K | 0.46% | 69 |
|
|
2017
Q3 | $7.95M | Buy |
42,656
+266
| +0.6% | +$47.1K | 0.53% | 60 |
|
|
2017
Q2 | $7.3M | Sell |
42,390
-3,163
| -7% | -$514K | 0.59% | 63 |
|
|
2017
Q1 | $7.47M | Buy |
45,553
+319
| +0.7% | +$53K | 0.63% | 55 |
|
|
2016
Q4 | $6.61M | Sell |
45,234
-3,669
| -8% | -$552K | 0.59% | 63 |
|
|
2016
Q3 | $8.16M | Buy |
48,903
+4,757
| +11% | +$804K | 0.74% | 51 |
|
|
2016
Q2 | $6.72M | Buy |
44,146
+6,312
| +17% | +$981K | 0.62% | 62 |
|
|
2016
Q1 | $5.67M | Buy |
37,834
+2,042
| +6% | +$303K | 0.54% | 71 |
|
|
2015
Q4 | $5.81M | Buy |
35,792
+1,450
| +4% | +$228K | 0.57% | 66 |
|
|
2015
Q3 | $4.75M | Buy |
34,342
+5,990
| +21% | +$944K | 0.49% | 73 |
|
|
2015
Q2 | $4.35M | Buy |
28,352
+2,415
| +9% | +$387K | 0.39% | 85 |
|
|
2015
Q1 | $4.15M | Sell |
25,937
-143
| -0.5% | -$22.5K | 0.4% | 81 |
|
|
2014
Q4 | $4.15M | Buy |
26,080
+1,504
| +6% | +$234K | 0.37% | 88 |
|
|
2014
Q3 | $3.45M | Buy |
24,576
+3,980
| +19% | +$520K | 0.32% | 99 |
|
|
2014
Q2 | $2.53M | Buy |
20,596
+15,645
| +316% | +$1.81M | 0.23% | 108 |
|
|
2014
Q1 | $611K | Sell |
4,951
-200
| -4% | -$24.3K | 0.06% | 173 |
|
|
2013
Q4 | $588K | Buy |
5,151
+215
| +4% | +$24.5K | 0.06% | 176 |
|
|
2013
Q3 | $552K | Hold |
4,936
| – | – | 0.06% | 167 |
|
|
2013
Q2 | $487K | Buy |
+4,936
| New | +$512K | 0.06% | 172 |
|
Other funds holding AMGN
Covington Capital Management's AMGN Position: Q3 2022 in Review
Covington Capital Management increased its Amgen (AMGN) stake by 0.43% in Q3 2022, buying an estimated $56.2K and bringing the position to 54,600 shares worth $12.3M. The position accounts for 0.53% of the portfolio, ranked #56.
Covington Capital Management first reported a position in AMGN in Q2 2013 and has held it in 38 quarters since. The position peaked at $13.3M in Q1 2022. 2,323 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.
- Covington Capital Management held 54,600 shares of Amgen worth $12.3M as of Q3 2022.
- Covington Capital Management bought 232 Amgen shares in Q3 2022, an estimated $56.2K.
- Amgen made up 0.53% of Covington Capital Management's portfolio in Q3 2022, its #56 holding.
- Covington Capital Management first reported a position in Amgen in Q2 2013 and has held it in 38 quarters since.
- Covington Capital Management's Amgen position peaked at $13.3M in Q1 2022.
- 2,323 funds tracked by Wall St. Rank held Amgen as of Q3 2022.
Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.